Winton Group LTD Tandem Diabetes Care Inc Transaction History

Winton Group LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$53.22 - $123.09 $146,674 - $339,236	-2,756 Reduced 20.76%	10,521 $623,000
Q1 2022 May 11, 2022	SELL	$101.89 - $150.09 $156,503 - $230,538	-1,536 Reduced 10.37%	13,277 $1.54 Million
Q4 2021 Feb 10, 2022	SELL	$118.18 - $153.21 $447,429 - $580,053	-3,786 Reduced 20.36%	14,813 $2.23 Million
Q3 2021 Oct 28, 2021	SELL	$93.51 - $129.4 $93,510 - $129,400	-1,000 Reduced 5.1%	18,599 $2.22 Million
Q2 2021 Aug 10, 2021	BUY	$77.0 - $100.19 $791,406 - $1.03 Million	10,278 Added 110.27%	19,599 $1.91 Million
Q1 2021 Jul 21, 2021	BUY	$81.28 - $104.34 $405,668 - $520,760	4,991 Added 115.27%	9,321 $823,000
Q4 2020 Feb 12, 2021	BUY	$86.4 - $121.75 $66,009 - $93,017	764 Added 21.42%	4,330 $414,000
Q3 2020 Oct 30, 2020	BUY	$95.43 - $116.09 $340,303 - $413,976	3,566 New	3,566 $405,000

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.97B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.